A&P LIFESCIENCE FUND, FI
•CLASE B
Cartera Renta Variable
| 2024-Q4 | ||||
|---|---|---|---|---|
1 | ELI LILLY AND CO | 167.777 € | 5.76% | 11.77% |
2 | ALNYLAM PHARMACEUTICALS INC | 150.237 € | 5.16% | 0.2% |
3 | VERONA PHARMA PLC ADR | 131.250 € | 4.51% | 232.33% |
4 | AXSOME THERAPEUTICS INC | 113.271 € | 3.89% | 8.76% |
5 | IONIS PHARMACEUTICALS INC | 84.454 € | 2.9% | 24.1% |
6 | BOSTON SCIENTIFIC CORP | 80.580 € | 2.77% | 20.02% |
7 | AMGEN INC | 77.540 € | 2.66% | 13.68% |
8 | VIKING THERAPEUTICS INC | 76.220 € | 2.62% | 21.45% |
9 | CRISPR THERAPEUTICS AG | 73.489 € | 2.52% | 24.59% |
10 | ABBOTT LABORATORIES | 70.250 € | 2.41% | 12.64% |
11 | AGIOS PHARMACEUTICALS INC | 67.574 € | 2.32% | 47.91% |
12 | SPRINGWORKS THERAPEUTICS INC ORDINARY SHARES | 64.387 € | 2.21% | 0.75% |
13 | SYNDAX PHARMACEUTICALS INC | 63.974 € | 2.2% | 33.37% |
14 | GENMAB A/S | 61.826 € | 2.12% | 14.06% |
15 | PROTAGONIST THERAPEUTICS INC | 58.685 € | 2.02% | 15.27% |
16 | NEUROCRINE BIOSCIENCES INC | 58.671 € | 2.02% | 2.6% |
17 | MEDTRONIC PLC | 55.553 € | 1.91% | 5.02% |
18 | MADRIGAL PHARMACEUTICALS INC | 53.947 € | 1.85% | 13.97% |
19 | ABBVIE INC | 53.895 € | 1.85% | 7.2% |
20 | EDWARDS LIFESCIENCES CORP | 50.483 € | 1.73% | 17.07% |
21 | MIRUM PHARMACEUTICALS INC | 47.928 € | 1.65% | 25.15% |
22 | CYTOKINETICS INC | 44.800 € | 1.54% | 10.16% |
23 | SAREPTA THERAPEUTICS INC | 44.276 € | 1.52% | 20.37% |
24 | IDEAYA BIOSCIENCES INC | 42.002 € | 1.44% | 24.26% |
25 | ARCUTIS BIOTHERAPEUTICS INC ORDINARY SHARES | 40.715 € | 1.4% | 285.05% |
26 | PLIANT THERAPEUTICS INC ORDINARY SHARES | 40.478 € | 1.39% | 26.77% |
27 | GE HEALTHCARE TECHNOLOGIES INC COMMON STOCK | 39.721 € | 1.36% | 3.82% |
28 | RESMED INC | 39.098 € | 1.34% | 23.63% |
29 | MINERALYS THERAPEUTICS INC | 38.429 € | 1.32% | 8.87% |
30 | KURA ONCOLOGY INC | 38.422 € | 1.32% | 56.23% |
31 | CULLINAN THERAPEUTICS INC | 37.059 € | 1.27% | 27.73% |
32 | KYMERA THERAPEUTICS INC ORDINARY SHARES | 36.449 € | 1.25% | 39.46% |
33 | CRINETICS PHARMACEUTICALS INC | 35.953 € | 1.24% | 18.12% |
34 | THERMO FISHER SCIENTIFIC INC | 34.672 € | 1.19% | 2.65% |
35 | DANAHER CORP | 32.593 € | 1.12% | 4.93% |
36 | PENUMBRA INC | 31.196 € | 1.07% | 36.54% |
37 | REGENERON PHARMACEUTICALS INC | 30.962 € | 1.06% | 29.87% |
38 | SANOFI SA ADR | 30.001 € | 1.03% | 2.86% |
39 | ROCHE HOLDING AG ADR | 28.536 € | 0.98% | 4.1% |
40 | AMICUS THERAPEUTICS INC | 28.143 € | 0.97% | 1.74% |
41 | BECTON DICKINSON & CO | 26.077 € | 0.9% | 0.45% |
42 | MOONLAKE IMMUNOTHERAPEUTICS CLASS A | 23.850 € | 0.82% | 27.43% |
43 | 89BIO INC ORDINARY SHARES | 23.567 € | 0.81% | 1.02% |
44 | ARVINAS INC | 23.368 € | 0.8% | 25.48% |
45 | BLUEPRINT MEDICINES CORP | 19.966 € | 0.69% | 16.26% |
46 | NOVARTIS AG ADR | 17.952 € | 0.62% | 5.42% |
47 | CG ONCOLOGY | 15.485 € | 0.53% | Nueva |
48 | STRUCTURE THERAPEUTI | 13.595 € | 0.47% | Nueva |
49 | 4D MOLECULAR THERAPEUTICS INC ORDINARY SHARES | 12.240 € | 0.42% | 72.54% |
50 | VERALTO CORP | 4820 € | 0.17% | 10.37% |
51 | SANDOZ GROUP AG ADR | 2973 € | 0.1% | 15.77% |
| 2025-Q2 | ||||
|---|---|---|---|---|
1 | ALNYLAM PHARMACEUTICALS INC | 158.798 € | 5.63% | 5.7% |
2 | VERONA PHARMA PLC ADR | 150.933 € | 5.35% | 15% |
3 | ELI LILLY AND CO | 128.301 € | 4.55% | 23.53% |
4 | AXSOME THERAPEUTICS INC | 104.417 € | 3.7% | 7.82% |
5 | BOSTON SCIENTIFIC CORP | 85.112 € | 3.02% | 5.62% |
6 | IONIS PHARMACEUTICALS INC | 83.833 € | 2.97% | 0.74% |
7 | CRISPR THERAPEUTICS AG | 79.767 € | 2.83% | 8.54% |
8 | ABBOTT LABORATORIES | 74.196 € | 2.63% | 5.62% |
9 | PROTAGONIST THERAPEUTICS INC | 73.806 € | 2.62% | 25.77% |
10 | SPRINGWORKS THERAPEUTICS INC ORDINARY SHARES | 73.553 € | 2.61% | 14.24% |
11 | AMGEN INC | 72.959 € | 2.59% | 5.91% |
12 | AGIOS PHARMACEUTICALS INC | 60.075 € | 2.13% | 11.1% |
13 | GENMAB A/S | 53.758 € | 1.91% | 13.05% |
14 | MEDTRONIC PLC | 53.247 € | 1.89% | 4.15% |
15 | MIRUM PHARMACEUTICALS INC | 51.810 € | 1.84% | 8.1% |
16 | ABBVIE INC | 49.448 € | 1.75% | 8.25% |
17 | NEUROCRINE BIOSCIENCES INC | 47.452 € | 1.68% | 19.12% |
18 | EDWARDS LIFESCIENCES CORP | 46.845 € | 1.66% | 7.21% |
19 | MADRIGAL PHARMACEUTICALS INC | 46.473 € | 1.65% | 13.85% |
20 | VIKING THERAPEUTICS INC | 44.088 € | 1.56% | 42.16% |
21 | SYNDAX PHARMACEUTICALS INC | 39.805 € | 1.41% | 37.78% |
22 | RESMED INC | 38.743 € | 1.37% | 0.91% |
23 | MINERALYS THERAPEUTICS INC | 37.099 € | 1.32% | 3.46% |
24 | ARCUTIS BIOTHERAPEUTICS INC ORDINARY SHARES | 35.993 € | 1.28% | 11.6% |
25 | GE HEALTHCARE TECHNOLOGIES INC COMMON STOCK | 33.054 € | 1.17% | 16.78% |
26 | IDEAYA BIOSCIENCES INC | 30.174 € | 1.07% | 28.16% |
27 | PENUMBRA INC | 29.610 € | 1.05% | 5.08% |
28 | ROCHE HOLDING AG ADR | 29.290 € | 1.04% | 2.64% |
29 | CYTOKINETICS INC | 27.638 € | 0.98% | 38.31% |
30 | METSERA INC | 26.430 € | 0.94% | Nueva |
31 | SANOFI SA ADR | 26.395 € | 0.94% | 12.02% |
32 | 89BIO INC ORDINARY SHARES | 25.993 € | 0.92% | 10.29% |
33 | BLUEPRINT MEDICINES CORP | 25.773 € | 0.91% | 29.08% |
34 | DANAHER CORP | 24.636 € | 0.87% | 24.41% |
35 | NOVO NORDISK AS ADR | 24.184 € | 0.86% | Nueva |
36 | THERMO FISHER SCIENTIFIC INC | 23.735 € | 0.84% | 31.54% |
37 | KURA ONCOLOGY INC | 22.356 € | 0.79% | 41.81% |
38 | CULLINAN THERAPEUTICS INC | 20.123 € | 0.71% | 45.7% |
39 | REGENERON PHARMACEUTICALS INC | 20.043 € | 0.71% | 35.27% |
40 | NOVARTIS AG ADR | 19.609 € | 0.7% | 9.23% |
41 | MOONLAKE IMMUNOTHERAPEUTICS CLASS A | 18.260 € | 0.65% | 23.44% |
42 | CRINETICS PHARMACEUTICALS INC | 17.763 € | 0.63% | 50.59% |
43 | VERA THERAPEUTICS IN | 17.410 € | 0.62% | Nueva |
44 | BECTON DICKINSON & CO | 17.390 € | 0.62% | 33.31% |
45 | IMMUNOCORE HOLDINGS | 16.453 € | 0.58% | Nueva |
46 | AMICUS THERAPEUTICS INC | 15.036 € | 0.53% | 46.57% |
47 | CG ONCOLOGY | 12.331 € | 0.44% | 20.37% |
48 | STRUCTURE THERAPEUTI | 9132 € | 0.32% | 32.83% |
49 | VERALTO CORP | 4197 € | 0.15% | 12.93% |
50 | SANDOZ GROUP AG ADR | 3525 € | 0.12% | 18.57% |
51 | SAREPTA THERAPEUTICS INC | 0 € | Vendida | |
52 | 4D MOLECULAR THERAPEUTICS INC ORDINARY SHARES | 0 € | Vendida | |
53 | KYMERA THERAPEUTICS INC ORDINARY SHARES | 0 € | Vendida | |
54 | PLIANT THERAPEUTICS INC ORDINARY SHARES | 0 € | Vendida | |
55 | ARVINAS INC | 0 € | Vendida | |